JPRN-UMIN000049974已完成Unknown
A Parallel Group Randomized Double-Blind Trial in Healthy Subjects Study on the Effect of 8 Weeks of Continuous Intake of Food Containing LPS on Allergic Reactions in the Nasal Eye - A Double-Blind Study on the Effects of 8-Week Consumption of Food Products Containing LPS on Nasal Eye Allergic Reactions
Innate Immune Network0 个研究点目标入组 60 人开始时间: 2023年1月6日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Currently taking medication or visiting a hospital for the treatment of any disease. 2) Currently under the supervision of a physician for exercise or diet therapy. 3) Persons who are at risk of developing allergies to the test food. 4) Pregnant women and nursing mothers. 5) Smokers. 6) Use of any medication during the 4 weeks prior to the start of the study that the study physician determines will affect participation in the study. 7) Inability to stop eating foods during the study period that the study physician determines may affect participation in the study. 8) Those who are participating or will participate in other clinical trials. 9) Persons who have donated at least 400 mL of blood at least 3 months prior to the date of consent or at least 200 mL of blood at least 1 month prior to the date of consent. 10) Any other person who has been judged by the investigator to be ineligible to participate in the study.
研究者
相似试验
进行中（未招募）
1 期
An irregular trial in which the identity of those receiving the intervention in twin groups is concealed from both the administrators and subject until the test is completed. The trial is to check the safety and efficacy of GWP42003-P versus Placebo as a joining therapy in Participants with Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment.Schizophrenia is neurodevelopmental syndrome, results from gradual alterations in brain connectivity. Can persist for years before psychosis emerges. Individuals have a 2 to 3 fold increased risk of death from a range of comorbid somatic conditions and suicide, the former attributable to unhealthy lifestyle, predisposition, and antipsychotic medication. Individuals typically smoke, can be overweight or obese, suffer from hypertension, dyslipidemias, metabolic syndrome, and diabetes.EUCTR2019-003369-16-ESGW Research Ltd.77
进行中（未招募）
1 期
An irregular trial in which the identity of those receiving the intervention in twin groups is concealed from both the administrators and subject until the test is completed. The trial is to check the safety and efficiency of GWP42003-P versus Placebo as a joining therapy in Participants with Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment.EUCTR2019-003369-16-PLGW Research Ltd.366
进行中（未招募）
1 期
Clinical Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated with Desmopressin Orally Disintegrating Tablets as compared to PlaceboocturiaEUCTR2012-004388-34-GBFerring Pharmaceuticals A/S5
招募中
3 期
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for OnchocerciasisOnchocerciasisPACTR202004639229710Medicines Development for Global Health1,000
已完成
不适用
Double-blind randomized parallel intergroup trial on the efficacy of the Lactobacillus rhamnosus L8020 containing gummi for oral healthJPRN-UMIN000026727Hiroshima University54